3 de
noviembre 2014
Tabla de
contenidos
Regulatory Matters
Bupropion
.......................................................................................
4
Diclofenac
......................................................................................
4
Methylphenidate
..............................................................................
5
Omalizumab
...................................................................................
5
Topiramate
.....................................................................................
5
Valproate
.......................................................................................
6
Safety of Medicines
Azathioprine
...................................................................................
7
Bo Ying Compound ® .......................................................................
7
Bromocriptine
.................................................................................
7
Denosumab
....................................................................................
8
Ferumoxytol
...................................................................................
8
Measles, Mumps, Rubella, Varicella
vaccine (MMRV) ........................... 8
Nitrofurantoin
.................................................................................
9
Zolpidem
........................................................................................
9
Signal
Febuxostat and Cardiac Failure
........................................................ 11
Pamidronic acid and Optic
Neuritis ................................................... 18
Fingolimod and Twave
Inversion...................................................... 21
Feature
Eleventh Meeting of the WHO
Advisory Committee on Safety of Medicinal
Products
(ACSoMP)......................................................................
27
No hay comentarios:
Publicar un comentario